ERBB2 and ductal breast carcinoma in situ: Our case, positioned at the most aggressive end of this spectrum, suggests that the HER2‐positive MPD‐DCIS phenotype itself can possess metastatic potential, and that its virulence can equal or even surpass that of cases with documented microinvasion.